chevron_leftBack
As of 17 June 2026, Lunai Bioworks, Inc. has a market cap of $12.9M USD, ranking #39943 globally and #5222 in the United States.
It ranks #3564 in the Healthcare sector, and #697 in the Biotechnology industry.
Key Stats
Market Cap
$12.9MUSD
Company Profile
warningChart data may be delayed
| 1d | 1w | 1m | 3m | 6m | 1y |
|---|---|---|---|---|---|
| 9% | 21% | 32% | -25% | -65% | -90% |
News
Loading...
LNAI Analyst Forecasts
Loading...
Markets
| Exchange | Ticker | Price |
|---|---|---|
|
LNAI
ISIN: US29350E3027
Shares Out.:
Shares Outstanding:
4.534M1
Shares Float:
2.947M2
TV:
TradingView:
SA:
Stock Analysis:
YF:
Yahoo Finance:
GF:
Google Finance:
NQ:
NASDAQ:
BA:
Barron's:
MS:
Morningstar:
|
2.85 USD |
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.
Similar Companies
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
NASDAQ: AMGN
|
$182.42B
1M%
|
23.9
|
|
NASDAQ: GILD
|
$159.92B
1M%
|
19.0
|
|
NASDAQ: NTRA
|
$27.6B
214K%
|
-
|
|
NYSE: IQV
|
$26.3B
204K%
|
20.0
|
|
NASDAQ: UTHR
|
$25.03B
194K%
|
20.4
|
|
NASDAQ: MRNA
|
$18.13B
140K%
|
-
|
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
EBR: ARGX
|
$47.99B
372K%
41.39B EUR
|
39.9
|
|
KRX: 207940
|
$45.17B
350K%
68.19T KRW
|
35.5
|
|
ASX: CSL
|
$42.62B
330K%
60.27B AUD
|
29.3
|
|
SIX: LONN
|
$42.46B
329K%
33.71B CHF
|
37.2
|
|
KRX: 068270
|
$28.33B
220K%
42.76T KRW
|
43.8
|
|
NASDAQ: BNTX
|
$25.69B
199K%
|
-
|
chevron_leftBack